Latham & Watkins LLP represented the initial purchasers in the offering.Haemonetics Corporation (NYSE: HAE) priced its offering of US$435 million aggregate principal amount of 0% Convertible Senior…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now